accreditation and certification

Intended Audience
This activity was developed for nurses and nurse practitioners who work with neonatal patients.

Learning Objectives
Upon completion of this activity, participants should be better able to:
Describe the pathophysiologic processes involved with PDA
Describe the diagnostic evidence for PDA, including ECHO and hemodynamic symptoms
Discuss the efficacy and safety of various treatment options based on the evidence,
including surgery and medical management with cyclo-oxygenase inhibitor therapy
Assess the timing of treatment initiation, eg, early vs. late, and how it can result in
different outcomes
Assimilate information on PDA, its co-morbidities and management into the daily care
of neonates

Accreditation and Certification
Annenberg Center for Health Sciences is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. Provider # 040207. The Annenberg Center designates this program for 1.5 contact hours of continuing education.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.5 contact hours may be earned for successful completion of this activity.

There is no charge for this activity. Statements of Credit will be provided by mail following activity participation, and upon completion and return of the evaluation form to the Annenberg Center for Health Sciences. Please allow 4-6 weeks for the delivery of your statement.

Disclosure
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

The faculty for this activity have disclosed that there will be no discussion about the use of products for non-FDA approved applications

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

If you need reasonable, special accommodations or have questions about access to any of our activities, please contact Pam Davidson by phone at 800-321-3690, by fax at 760-773-4550, or by
e-mail to .

This activity is supported by an independent educational grant from Ovation Pharmaceuticals, Inc.

This activity is an enduring material and consists of a Web page activity. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1.5 hours.

This activity was originally released in February 2008 and is eligible for credit through January 2009.